FN1
EmergingFN1/fibronectin is a research marker of tumor invasion and fibrosis, not yet a standardized clinical diagnostic test.
Fibronectin helps cells stick together and is involved in wound healing. Higher levels in and around tumors have been linked to more invasive cancer behavior in research studies, though it isn't yet a standard clinical test.
Fibronectin 1 (FN1) encodes fibronectin, an extracellular matrix glycoprotein involved in cell adhesion, migration, and wound healing.
Elevated tissue or plasma fibronectin has been studied as a marker of fibrosis and tumor invasion in several cancers, reflecting its role in remodeling the extracellular matrix that surrounds and supports tumor growth and spread.
Measured via immunohistochemistry (tissue) or serum immunoassay (research settings); fibronectin functions more as a research biomarker than a standardized clinical diagnostic test in current oncology practice.
No fibronectin-targeted therapies or standardized fibronectin-based treatment decisions are currently part of routine clinical care, though it remains an active area of tumor microenvironment research.
Reflects extracellular matrix remodeling relevant to tumor growth and metastasis in ongoing research.
- General oncology reference literature on fibronectin in tumor invasion and extracellular matrix remodeling research.